1. Home
  2. BCAB vs TC Comparison

BCAB vs TC Comparison

Compare BCAB & TC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCAB
  • TC
  • Stock Information
  • Founded
  • BCAB 2007
  • TC 2010
  • Country
  • BCAB United States
  • TC China
  • Employees
  • BCAB N/A
  • TC N/A
  • Industry
  • BCAB Medicinal Chemicals and Botanical Products
  • TC Business Services
  • Sector
  • BCAB Health Care
  • TC Consumer Discretionary
  • Exchange
  • BCAB Nasdaq
  • TC Nasdaq
  • Market Cap
  • BCAB 31.5M
  • TC 26.4M
  • IPO Year
  • BCAB 2020
  • TC 2018
  • Fundamental
  • Price
  • BCAB $0.72
  • TC $14.80
  • Analyst Decision
  • BCAB Hold
  • TC
  • Analyst Count
  • BCAB 3
  • TC 0
  • Target Price
  • BCAB $1.00
  • TC N/A
  • AVG Volume (30 Days)
  • BCAB 1.1M
  • TC 29.6K
  • Earning Date
  • BCAB 11-06-2025
  • TC 08-29-2025
  • Dividend Yield
  • BCAB N/A
  • TC N/A
  • EPS Growth
  • BCAB N/A
  • TC N/A
  • EPS
  • BCAB N/A
  • TC N/A
  • Revenue
  • BCAB $11,000,000.00
  • TC $5,115,721.00
  • Revenue This Year
  • BCAB N/A
  • TC N/A
  • Revenue Next Year
  • BCAB N/A
  • TC N/A
  • P/E Ratio
  • BCAB N/A
  • TC N/A
  • Revenue Growth
  • BCAB N/A
  • TC N/A
  • 52 Week Low
  • BCAB $0.24
  • TC $9.20
  • 52 Week High
  • BCAB $2.53
  • TC $86.00
  • Technical
  • Relative Strength Index (RSI)
  • BCAB 56.79
  • TC 54.68
  • Support Level
  • BCAB N/A
  • TC $13.00
  • Resistance Level
  • BCAB $0.84
  • TC $22.46
  • Average True Range (ATR)
  • BCAB 0.07
  • TC 2.29
  • MACD
  • BCAB -0.00
  • TC 0.39
  • Stochastic Oscillator
  • BCAB 85.96
  • TC 37.49

About BCAB BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of specific and selective antibody-based therapeutics for the treatment of solid tumor cancer. Its pipeline products comprise mecbotamab vedotin (BA3011), ozuriftamab vedotin (BA3021), and evalstotug (BA3071), and its Phase 1 clinical trial of BA3182 (CAB-EpCAM x CAB-CD3) and Bispecific antibody programs.

About TC TuanChe Limited

Token Cat Ltd is an omnichannel automotive marketplace in China. The company operates in one segment, providing auto shows, special promotion event services, virtual dealerships, online marketing services, and more. It organizes auto shows to facilitate transactions between consumers and auto dealers, which include auto dealers, automakers, and automotive service providers. It offers services through its online platform and offline events.

Share on Social Networks: